BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29388807)

  • 1. Spectrum of MRI brain lesion patterns in neuromyelitis optica spectrum disorder: a pictorial review.
    Wang KY; Chetta J; Bains P; Balzer A; Lincoln J; Uribe T; Lincoln CM
    Br J Radiol; 2018 Jun; 91(1086):20170690. PubMed ID: 29388807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain and cord imaging features in neuromyelitis optica spectrum disorders.
    Cacciaguerra L; Meani A; Mesaros S; Radaelli M; Palace J; Dujmovic-Basuroski I; Pagani E; Martinelli V; Matthews L; Drulovic J; Leite MI; Comi G; Filippi M; Rocca MA
    Ann Neurol; 2019 Mar; 85(3):371-384. PubMed ID: 30635936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.
    Huh SY; Min JH; Kim W; Kim SH; Kim HJ; Kim BJ; Kim BJ; Lee KH
    Mult Scler; 2014 May; 20(6):695-704. PubMed ID: 24072726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative 7T MRI does not detect occult brain damage in neuromyelitis optica.
    Pasquier B; Borisow N; Rasche L; Bellmann-Strobl J; Ruprecht K; Niendorf T; Derfuss TJ; Wuerfel J; Paul F; Sinnecker T
    Neurol Neuroimmunol Neuroinflamm; 2019 May; 6(3):e541. PubMed ID: 30882018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: A cohort of Latin American patients.
    Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Antunes Barreira A; Armas E; Chiganer E; de Aquino Cruz C; Di Pace JL; Hryb JP; Lavigne Moreira C; Lessa C; Molina O; Perassolo M; Soto A; Caride A
    Mult Scler Relat Disord; 2018 Jan; 19():73-78. PubMed ID: 29156226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occurrence of Asymptomatic Acute Neuromyelitis Optica Spectrum Disorder-Typical Brain Lesions during an Attack of Optic Neuritis or Myelitis.
    Kim SH; Hyun JW; Joung A; Lee SH; Kim HJ
    PLoS One; 2016; 11(12):e0167783. PubMed ID: 27936193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Lee CY; Mak HK; Chiu PW; Chang HC; Barkhof F; Chan KH
    J Magn Reson Imaging; 2018 Jun; 47(6):1601-1609. PubMed ID: 28990252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of myelin water fraction values in periventricular white matter lesions between multiple sclerosis and neuromyelitis optica spectrum disorder.
    Jeong IH; Choi JY; Kim SH; Hyun JW; Joung A; Lee J; Kim HJ
    Mult Scler; 2016 Oct; 22(12):1616-1620. PubMed ID: 26920375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature.
    Ikeda A; Watanabe Y; Kaba H; Kaneko K; Takahashi T; Takeshita S
    Brain Dev; 2019 Apr; 41(4):367-372. PubMed ID: 30447856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI to differentiate multiple sclerosis, neuromyelitis optica, and myelin oligodendrocyte glycoprotein antibody disease.
    Carnero Contentti E; Okuda DT; Rojas JI; Chien C; Paul F; Alonso R
    J Neuroimaging; 2023; 33(5):688-702. PubMed ID: 37322542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain lesion distribution criteria distinguish demyelinating diseases in China.
    Cai MT; Zhang YX; Zheng Y; Yang F; Fang W; Shen CH; Ding MP
    Ann Clin Transl Neurol; 2019 Oct; 6(10):2048-2053. PubMed ID: 31566925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffusion tensor imaging of normal-appearing white matter in patients with neuromyelitis optica spectrum disorder and multiple sclerosis.
    Kim SH; Kwak K; Hyun JW; Joung A; Lee SH; Choi YH; Lee JM; Kim HJ
    Eur J Neurol; 2017 Jul; 24(7):966-973. PubMed ID: 28643955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.
    Pache F; Zimmermann H; Finke C; Lacheta A; Papazoglou S; Kuchling J; Wuerfel J; Hamm B; Ruprecht K; Paul F; Brandt AU; Scheel M
    Eur Radiol; 2016 Dec; 26(12):4413-4422. PubMed ID: 27012555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.
    Mealy MA; Mossburg SE; Kim SH; Messina S; Borisow N; Lopez-Gonzalez R; Ospina JP; Scheel M; Yeshokumar AK; Awad A; Leite MI; Arango JJ; Paul F; Palace J; Kim HJ; Levy M
    Mult Scler Relat Disord; 2019 Feb; 28():64-68. PubMed ID: 30554040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain MRI characteristics in neuromyelitis optica spectrum disorders: A large multi-center retrospective study in China.
    Cao G; Duan Y; Zhang N; Sun J; Li H; Li Y; Li Y; Zeng C; Han X; Zhou F; Huang M; Zhuo Z; Haller S; Liu Y
    Mult Scler Relat Disord; 2020 Nov; 46():102475. PubMed ID: 32898832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
    Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the cranial magnetic resonance imaging features of neuromyelitis optica spectrum disorder versus multiple sclerosis in Taiwanese patients.
    Liao MF; Chang KH; Lyu RK; Huang CC; Chang HS; Wu YR; Chen CM; Chu CC; Kuo HC; Ro LS
    BMC Neurol; 2014 Nov; 14():218. PubMed ID: 25433369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.
    Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD
    Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.